tirzepatide phase 2 Tirzepatide: First Approval | Drugs TrimRX | Tirzepatide Results Timeline:

Every day without access means worsening health, higher long-term costs, and unnecessary suffering which is why we push for solutions now, not years from now

Salom Vendrell C, Garca Tercero E, Moro Hernndez JB, Cedeno-Veloz BA

Well review your current or past treatment plan, evaluate your progress, and create a personalized approach that may include transitioning to our prescription injections with weekly check-ins and flat-rate pricing.

While both companies that have a monopoly on these drugs (Novo Nordisk and Eli Lilly) have enjoyed an incredible run-up from 2020 to 2024, both are now in a drawdown

So the reason for that is because unlike the physician-administered or provider-administered biosimilars, the Humira biosimilar is a self-administered drug, and its provided through the pharmacy benefit

Many patients report this is when they truly start believing the medication is working